Skip to content

    Platinum Industr

    PLATIND
    Chemicals·13 May 2026
    Management Summary

    Platinum Industries delivered a robust Q4 FY26, with consolidated revenue growing 37% YoY to INR 132 crores and PAT surging 164% YoY to INR 14.8 crores, driven by product mix improvement. The company is strategically expanding with a new Egypt facility set to contribute from Q3 FY27 and has launched an Oleo Chemicals segment. Despite temporary raw material volatility and increased employee costs, management is optimistic about achieving over 40% revenue growth in FY27 and maintaining EBITDA margins between 13-15%.

    Highlights

    5
    • Q4 FY26 consolidated revenue from operations grew 37% YoY to INR 132 crores, driven by improved product mix and sustained demand.

    • Q4 FY26 consolidated EBITDA grew 95% YoY to INR 15.3 crores, with margins expanding 350bps to 11.6%.

    • Q4 FY26 consolidated PAT grew 164% YoY to INR 14.8 crores, with margins expanding 543bps to 11.24%.

    • The company is targeting over 40% revenue growth in FY27 and a 35% CAGR from FY26 to FY29, supported by Egypt facility ramp-up and product diversification.

    • Sales for the new Oleo Chemicals segment commenced in April, with a target of INR 55-60 crores revenue in FY27.

    Concerns

    3
    • Raw material price volatility in March and April due to geopolitical scenarios led to temporary gross margin hiccups.

    • Increased employee costs due to new facility and senior-level hiring, though expected to normalize as sales from the new facility optimize.

    • A time lag exists in passing on raw material price increases to customers, which can temporarily impact margins.

    Key financials

    Metrics

    7

    Periods

    2

    Consolidated FY26

    3
    • Revenue
      ₹450 Cr
      YoY+15%
    • EBITDA
      ₹59.8 Cr
      YoY+4.2%
    • PAT
      ₹51.2 Cr
      YoY+3.7%

    Consolidated Q4 FY26

    4
    • Revenue
      ₹132 Cr
      YoY+37%
    • EBITDA
      ₹15.3 Cr
      YoY+95%
    • EBITDA Margin
      11.6%
    • PAT
      ₹14.8 Cr
      YoY+1.6%

    Segment breakdown

    CPVC Business
    ₹110 Cr Revenue (FY26)24.4% Share of Consolidated Revenue (FY26)
    List

    Capital allocation

    3
    medium confidence
    CategoryHeadline
    Capex

    Capex disclosed

    Debt

    Debt disclosed

    Liquidity

    Liquidity disclosed

    Our liquidity position remains strong to fund our ongoing operations and future investments.

    Guidance & targets

    10
    CategoryTargetPriority
    Revenue
    Revenue Growth
    more than 40%
    High
    Revenue
    Revenue CAGR
    35%
    High
    Revenue
    Egypt revenue contribution
    10% of topline
    High
    Revenue
    Oleo chemicals revenue
    INR 55 crores to INR 60 crores
    High
    Revenue
    Egypt plant peak revenue potential
    around INR 300 cr. over three years, more than INR 600 crores at peak
    Medium
    Capacity
    Egypt facility commercial operations start
    Q3 FY27
    High
    Capacity
    Oleo chemicals plant readiness
    within one and a half year
    Medium
    Margin
    EBITDA margin
    13% to 15%
    High
    Margin
    Egypt gross margins vs India
    at least at the same level of India, but definitely higher
    High
    Profitability
    Egypt breakeven utilization
    30% to 35%
    High

    Egypt Plant Commercial Operations

    Q3 FY27
    CurrentExpected Q3 FY27
    TargetCommercial operations commenced

    Why it matters

    Verification of the new international facility's operational start is key to realizing planned revenue diversification and growth.

    The facility is expected to start commercial operations in Q3 financial year 2027.

    How to verify

    guidance_and_targets[metric='Egypt facility commercial operations start']

    Risks & concerns

    2
    RiskSeverity

    Raw Material Price Volatility

    Geopolitical scenario caused raw material price spikes in March and April, leading to temporary gross margin pressure and a time lag in passing on costs.Management acknowledged

    high

    Increased Employee Costs

    Employee costs increased due to new facility setup and senior-level hiring, though expected to normalize as sales from the new facility optimize.Management acknowledged

    medium

    Q&A highlights

    8

    “About 10% of the topline will come from Egypt operation and rest from Indian facility in FY27. And CPVC we are quite hopeful of achieving very decent growth in FY27.”

    Provides clarity on the geographical and product-wise drivers for the ambitious FY27 revenue growth target.

    asked by Bhargav Buddhadev

    3 min read5 chapters

    Detailed Narrative

    01

    Robust Q4 & FY26 Performance Driven by Product Mix

    Platinum Industries reported a strong Q4 FY26, with consolidated revenue from operations growing 37% year-on-year to INR 132 crores. This performance was attributed to an improved product mix and sustained demand, particularly in the PVC and CPVC pipe and fitting segments. Consolidated EBITDA for the quarter increased by 95% YoY to INR 15.3 crores, expanding margins by 350 basis points to 11.6%. For the full financial year 2026, consolidated revenue stood at INR 450 crores, reflecting a 15% YoY growth, with PAT at INR 51.2 crores, up 3.7% YoY.

    02

    Strategic International Expansion with Egypt Facility

    The company is making significant strides in its international expansion strategy with a new manufacturing facility in Egypt. This facility is expected to commence commercial operations in Q3 FY27 and is projected to contribute approximately 10% to the company's total topline in FY27. The Egypt plant, with a similar capacity of 60,000 metric tonnes per annum, aims to serve American markets (North and South America) with CPVC and metallic soaps, and is expected to reach a peak revenue potential of over INR 600 crores. Management anticipates the Egypt operations to breakeven at 30-35% utilization and achieve gross margins at least on par with, or higher than, Indian markets.

    03

    Diversification into Oleo Chemicals and Other Polymers

    Platinum Industries has successfully ventured into the Oleo Chemicals segment, with sales commencing in April 2026. The company is targeting INR 55-60 crores in revenue from oleo chemicals in FY27, expecting to reach this run rate by Q2. A dedicated manufacturing plant for oleo-based derivatives is planned to be ready within the next one and a half years. This move is part of a broader strategy to diversify the product portfolio beyond PVC and CPVC, developing products for other polymers like LLDPE, LDPE, HDPE, and PET, to mitigate volatility in any single polymer segment.

    04

    Ambitious Growth Outlook and Margin Management

    Management reiterated ambitious growth targets, aiming for over 40% revenue growth in FY27 and a 35% CAGR from FY26 to FY29. They expect to maintain EBITDA margins between 13-15% for FY27. While Q4 FY26 saw some temporary gross margin pressure due to raw material price spikes from geopolitical scenarios, the company has been able to pass on costs to customers, albeit with a time lag. Strategic inventory management and a focus on value-added products like CPVC, where gross margins have improved from 6-7% to 18-20%, are key to sustaining profitability.

    05

    Capacity Augmentation and R&D-Driven Product Development

    The company continues to invest in capacity augmentation, with Unit 2 in India having an installed capacity of 60,000 tonnes and Unit 1 at 25,000 tonnes. The new Egypt facility will add another 60,000 tonnes. Platinum Industries emphasizes its R&D-driven approach, which has enabled the development of innovative products and formulations. This focus has allowed them to capture a significant share in the evolving CPVC market, where their additives are crucial, and to expand into new product categories like oleo chemicals with a strong market understanding.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.